Related Experiment Video
Updated: Jun 16, 2026
06:37
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Quantitative validation and comparison of multiplex cytokine kits.
Joanna L Richens1, Richard A Urbanowicz, Rebecca Metcalf
1Cell Biophysics Group, School of Biology, University of Nottingham, UK. joanna.richens@nottingham.ac.uk
Journal of Biomolecular Screening
|February 24, 2010
Summary
Multiplexing technologies like Luminex kits offer reproducible cytokine pattern analysis for disease biomarker studies. Cytokine Bead Array (CBA) kits showed issues with standards, impacting reliability.
Area of Science:
- Biomolecular analysis
- Proteomics
- Disease diagnostics
Background:
- Biomarker studies increasingly focus on biomolecular patterns for comprehensive disease depiction.
- Multiplexing technologies are vital for analyzing these patterns but require validation for accuracy.
- Ensuring reproducibility and precision is critical for reliable protein identification in multiplex assays.
Purpose of the Study:
- To evaluate the reproducibility and precision of Cytokine Bead Array (CBA) and Luminex multiplexing kits.
- To compare cytokine concentration measurements from CBA and Luminex kits with those from enzyme-linked immunosorbent assay (ELISA).
Main Methods:
- Utilized Cytokine Bead Array (CBA) and Luminex kits for multiplex cytokine analysis.
- Performed comparative concentration measurements against enzyme-linked immunosorbent assay (ELISA).
- Assessed assay properties including reproducibility and precision.
Main Results:
- Luminex kits demonstrated high reproducibility and reliability in cytokine measurements.
- Cytokine Bead Array (CBA) kits exhibited issues with aberrant standards, affecting their reliability.
- Absolute cytokine concentrations varied depending on the specific detection kit used.
- Good correlations were observed between all tested multiplexing technologies and ELISA.
Conclusions:
- Luminex kits are reliable for multiplex cytokine analysis in biomarker discovery.
- Cytokine Bead Array (CBA) kits require further optimization due to standardization issues.
- Multiplexing technologies show promise for disease pattern deciphering, but careful validation is essential.
